Table 2 Characteristics of 30–64-year-old study populations involved in the Framingham Risk Score for hard coronary heart disease (FRSCHD) and Framingham Risk Score for cardiovascular disease (FRSCVD) calculations by ethnicity and sex.
Males | Females | |||||
|---|---|---|---|---|---|---|
Hungarian general (n = 121) | Hungarian Roma (n = 62) | p-value | Hungarian general (n = 163) | Hungarian Roma (n = 196) | p-value | |
Mean (95% CI) | Mean (95% CI) | |||||
Age (years) | 47.98 (46.35–49.60) | 49.60 (47.11–52.08) | 0.244 | 47.31 (45.85–48.76) | 46.29 (45.03–47.55) | 0.274 |
Total cholesterol levels (mmol/L) | 5.13 (4.96–5.31) | 5.05 (4.79–5.32) | 0.563 | 5.11 (4.94–5.28) | 5.13 (4.97–5.28) | 0.931 |
HDL-C levels (mmol/L) | 1.31 (1.24–1.38) | 1.23 (1.14–1.33) | 0.211 | 1.47 (1.41–1.53) | 1.29 (1.24–1.34) | < 0.001 |
Systolic blood pressure (mmHg) | 130.76 (128.43–133.08) | 130.98 (126.24–135.73) | 0.370 | 124.86 (122.65–127.07) | 124.94 (122.49–127.40) | 0.479 |
Prevalence (%) | p-value | Prevalence (%) | p-value | |||
|---|---|---|---|---|---|---|
Smokers | 35.54 (27.43–44.33) | 58.06 (45.65–69.75) | 0.004 | 33.74 (26.82–41.24) | 68.37 (61.62–74.57) | < 0.001 |
Treated for high blood pressure | 25.62 (18.48–33.91) | 37.10 (25.88–49.49) | 0.107 | 31.90 (25.11–39.33) | 35.20 (28.77–42.07) | 0.510 |
Diabetesa | 10.74 (6.16–17.18) | 9.68 (4.14–18.86) | 0.823 | 8.59 (5.01–13.62) | 16.33 (11.66–21.98) | 0.029 |
Receiving lipid-lowering therapyb | 4.96% (2.10–9.93) | 12.90% (6.29–22.87) | 0.056 | 4.91 (2.35–9.05) | 11.22 (7.38–16.21) | 0.031 |
